Invivyd (IVVD) EPS (Basic) (2021 - 2025)

Invivyd (IVVD) posted EPS (Basic) of -$0.07 for Q4 2025, down 2.1% on a QoQ basis from -$0.07 in Q3 2025, and up 54.51% year-over-year from -$0.05 in Q4 2024.

Invivyd (IVVD) EPS (Basic) (2021 - 2025) Analysis & Trends

Invivyd's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.07 for Q4 2025.

  • Quarterly EPS (Basic) rose 54.51% year-over-year to -$0.07 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.33 (up 81.46% YoY) and the FY2025 annual result came in at -$1.79, up 49.71% from the prior year.
  • EPS (Basic) was -$0.07 for Q4 2025 at Invivyd, down from -$0.07 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.07 in Q3 2025 and bottomed at -$178.86 in Q2 2021.
  • A 5-year average of -$9.92 and a median of -$0.49 in 2022 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2022 — EPS (Basic) jumped 99.7% — and 2024, when it tumbled 87.64%.
  • Invivyd's EPS (Basic) stood at -$1.95 in 2021, then surged by 77.12% to -$0.45 in 2022, then tumbled by 55.71% to -$0.7 in 2023, then soared by 77.56% to -$0.16 in 2024, then surged by 54.51% to -$0.07 in 2025.
  • Business Quant data shows IVVD's EPS (Basic) at -$0.07 in Q4 2025, -$0.07 in Q3 2025, and -$0.13 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 0.00
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn - -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn - 0.00
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn 6.99
7 Belite Bio 63.57 Bn 63.57 Bn - 0.00
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn 7.59
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn 1.55
10 Invivyd 106.01 Mn -120.67 Mn 16.07 Mn -0.07

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.07
Sep 30, 2025 -0.07
Jun 30, 2025 -0.13
Mar 31, 2025 -0.14
Dec 31, 2024 -0.16
Sep 30, 2024 -0.53
Jun 30, 2024 -0.42
Mar 31, 2024 -0.69
Dec 31, 2023 -0.70
Sep 30, 2023 -0.41
Jun 30, 2023 -0.50
Mar 31, 2023 -0.37
Dec 31, 2022 -0.45
Sep 30, 2022 -0.49
Jun 30, 2022 -0.54
Mar 31, 2022 -1.03
Dec 31, 2021 -1.95
Sep 30, 2021 -0.98
Jun 30, 2021 -178.86